Novartis

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer pati…

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...